Sign In
Buy SF
$82.91
+0.280 (+0.339%)
At Close: Jul 31, 2026
Tobin Scientific Closes $65M Investment to Accelerate Growth Across Life Sciences Infrastructure
09:15am, Wednesday, 07'th May 2025
BEVERLY, Mass. , May 7, 2025 /PRNewswire/ -- Tobin Scientific, a leading provider of cGMP storage, biorepository services, and specialized logistics for the life sciences industry, announced today th
Best in breed companies like Nvidia will be fine, despite tariff headwinds, says Stifel's Ruben Roy
05:21pm, Tuesday, 06'th May 2025
Ruben Roy, Stifel senior analyst, joins 'Closing Bell Overtime' to talk AMD earnings, recent comments from Nvidia CEO Jensen Huang, the broader AI landscape, and more.
Down But Not Out, Stifel Emerges From Rocky First Quarter
05:25am, Thursday, 01'st May 2025
Stifel Financial faced multiple legal setbacks in Q1 2025, leading to a 20% stock drop and missed earnings expectations due to legal charges. In Q1 2025, the company recorded record net revenues of $1
KBW Announces 2025 Bank Honor Roll Award Winners
08:30am, Tuesday, 29'th Apr 2025
NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Keefe, Bruyette & Woods, Inc., a leading specialist investment bank to the financial services and fintech sectors, and a wholly owned subsidiary of Stifel
Why Stifel Financial Stock Was Down on Wednesday
06:44pm, Wednesday, 23'rd Apr 2025
On Wednesday, optimism was in the air on the stock market, as investors were hopeful that the current tariff war might not be as damaging as feared. They were selective about the stocks they piled int
Q3 will be a better read on tariff impact for Texas Instruments, says Stifel's Svanberg
05:35pm, Wednesday, 23'rd Apr 2025
Tore Svanberg, Stifel Managing Director, joins 'Closing Bell Overtime' to talk Texas Instruments earnings.
Stifel Financial Corp. (SF) Q1 2025 Earnings Call Transcript
02:40pm, Wednesday, 23'rd Apr 2025
Stifel Financial Corp. (NYSE:SF ) Q1 2025 Earnings Conference Call April 23, 2025 9:30 AM ET Company Participants Joel Jeffrey - Head, Investor Relations Ron Kruszewski - Chairman & Chief Executive Of
Stifel Financial (SF) Lags Q1 Earnings and Revenue Estimates
09:15am, Wednesday, 23'rd Apr 2025
Stifel Financial (SF) came out with quarterly earnings of $0.49 per share, missing the Zacks Consensus Estimate of $1.61 per share. This compares to earnings of $1.49 per share a year ago.
Stifel Reports First Quarter 2025 Results
07:00am, Wednesday, 23'rd Apr 2025
ST. LOUIS, April 23, 2025 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today reported net revenues of $1.26 billion for the three months ended March 31, 2025, compared with $1.16 billion a ye
Stifel Financial (SF) Earnings Expected to Grow: What to Know Ahead of Q1 Release
11:07am, Wednesday, 16'th Apr 2025
Stifel (SF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ACG Metals: Stifel initiates research coverage with 'buy'' call
02:48am, Wednesday, 09'th Apr 2025
Stifel Nicolaus Europe has begun covering ACG Metals Ltd (LSE:ACG, OTC:ACGAF) with a ‘buy' rating, offering investors an independent analysis of the company's strategy and operations. The research i
Stifel CEO on Trump's tariffs: The first step to a recalibration of unfair trade policies
02:31pm, Tuesday, 08'th Apr 2025
Ron Kruszweski, Stifel chairman and CEO, joins 'The Exchange' to discuss the recent market volatility, the chief executive's expectations for the year, and what could further interrupt business this y
Stifel Completes Acquisition of B. Riley Employee Advisors
05:53pm, Monday, 07'th Apr 2025
ST. LOUIS, April 07, 2025 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today announced the completion of its acquisition of 36 B. Riley employee advisors, representing total assets under mana
We should analyze Trump tariffs as a 'stagflationary shock', says Stifel's Barry Bannister
09:39am, Thursday, 03'rd Apr 2025
Barry Bannister, Stifel chief equity strategist, joins 'Squawk Box' to discuss President Trump's tariff announcement, impact on the markets, economic outlook, where investors can find opportunities ri
Stifel's Paul Matteis says look for biotech names not dependent on the FDA amid sector uncertainty
02:05pm, Monday, 31'st Mar 2025
Paul Matteis, Stifel head of biotech research, joins 'The Exchange' to discuss the biotech trade under a new FDA amid the top vaccine official resigning.
